FDA Warning Cites Ageless Derma's Anti-Wrinkle, Brightening Claims

In a warning letter published on FDA's website May 2, the agency identifies two Ageless Derma products as unapproved new drugs due to label and website claims touting body structure/function effects. The laundry list of offending claims offers a resource for companies to use in their own claims-compliance efforts.

More from Archive

More from HBW Insight